Acceleron Pharma (XLRN) PT Raised to $171 at Citi
Tweet
Share
E-mailGet Alerts XLRN Hot Sheet
Price: $178.75 --0%
Rating Summary:
11 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 24 | New: 19
Rating Summary:
11 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 24 | New: 19
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz raised the price target on Acceleron Pharma (NASDAQ: XLRN) to $171.00 (from $137.00) while maintaining a Buy rating.
You May Also Be Interested In
- R5 Capital Downgrades Kroger (KR) to Sell, 'particularly vulnerable'
- MoffettNathanson sees upside for DoorDash and Uber, Lyft on the 'losing end'
- Krung Thai Bank PCL (KTB:TB) PT Raised to THB20 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
